CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-21 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +4,200 | 4,200 | ||
| 2025-06-11 | DUBIN STEVE Director | Grant or award | +5,900 | 22,700 | ||
| 2025-06-11 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-08-21 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2024-08-21 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-08-21 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −18,500 | 0 | ||
| 2024-08-21 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2024-08-21 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −18,500 | 0 | ||
| 2024-08-21 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2024-08-21 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −26,400 | 0 | ||
| 2024-08-21 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-06-05 | DUBIN STEVE Director | Grant or award | +5,900 | 16,800 | ||
| 2024-06-05 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2023-08-14 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2023-08-14 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-08-14 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −18,500 | 0 | ||
| 2023-08-14 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2023-08-14 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −18,500 | 0 | ||
| 2023-08-14 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2023-08-14 | DUBIN STEVE Director | Returned to the company · Stock Option (Right to Buy) | −26,400 | 0 |
Page 1 of 2 · 27 trades